Welcome to our dedicated page for Lazard SEC filings (Ticker: LAZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to untangle Lazard’s dual revenue story—advisory fees versus asset-management AUM—from hundreds of pages of SEC text? Each 10-K, 10-Q, or 8-K can hide critical clues about banker incentive pay, restructuring pipelines, and market-moving mandates.
Stock Titan’s AI transforms those technical filings into clear, searchable intelligence. Whether you’re scanning a Lazard quarterly earnings report 10-Q filing for segment revenue, or need Lazard insider trading Form 4 transactions before the next merger announcement, our platform delivers answers in seconds. Real-time feeds pull every submission straight from EDGAR, then generate concise summaries that make Lazard SEC filings explained simply a reality.
Here’s what you can explore today:
- 10-K & 10-Q – Track advisory backlog, AUM flows, and fee percentages with Lazard earnings report filing analysis and Lazard annual report 10-K simplified.
- 8-K material events – Get Lazard 8-K material events explained moments after they’re posted—ideal for spotting sudden leadership moves or deal announcements.
- Form 4 – Monitor Lazard Form 4 insider transactions real-time and flag significant Lazard executive stock transactions Form 4.
- DEF 14A proxy – Unpack Lazard proxy statement executive compensation to understand bonus pools and retention grants.
From “understanding Lazard SEC documents with AI” to locating footnotes on contingent fees, Stock Titan’s expert analysis bridges the gap between raw disclosures and actionable insight—so analysts, portfolio managers, and corporate-finance professionals can focus on decisions, not document hunting.
Lazard (LAZ) Q2-25 10-Q highlights: Net revenue rose 16% YoY to $796 M on stronger Financial Advisory fees (+21% to $493 M) and modest Asset Management growth (+3% to $276 M). Operating expenses climbed 13% to $703 M, but the cost ratio improved, lifting operating income 46% to $93 M. Net income attributable to Lazard increased 11% to $55 M; diluted EPS advanced to $0.52 from $0.49.
Year-to-date (6 M): Net revenue was flat at $1.44 B, while tighter expenses trimmed the comp ratio and pushed net income up 36% to $116 M (EPS $1.08 vs $0.84).
Balance sheet & cash flow: Cash and cash equivalents fell to $978 M from $1.31 B at 12/31/24, reflecting negative operating cash flow of $168 M driven by incentive compensation payments and working-capital swings. Senior debt remained steady at $1.69 B. Shareholders’ equity improved 17% to $742 M due to earnings and lower treasury stock after share deliveries. Book value per share is roughly $7.57.
Key metrics: Q2 operating margin 11.7% (vs 9.3%); comp & benefits 65% of net revenue (vs 66%). Diluted share count rose 4% YoY to 104.9 M.